Semaglutide
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (S
Novo Nordisk · Phase 3 · Completed · Enrollment 573
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Insuline glargine U100 (reduced) + semaglutide | n/r | n/r | n/r | n/r |
| Insuline glargine U100 (titrated) | n/r | n/r | n/r | n/r |
Not shown
- Insuline glargine U100 (reduced) + semaglutide: endpoint not reported
- Insuline glargine U100 (titrated): endpoint not reported